Biography
Dr. Kenneth Rosenzweig is the Chair of Radiation Oncology at Mount Sinai and a leading expert in radiation therapy for mesothelioma. He has developed intensity-modulated radiation therapy (IMRT) protocols specifically designed for pleural mesothelioma, working as part of the multidisciplinary mesothelioma team alongside the thoracic surgery group. Dr. Rosenzweig trained at Memorial Sloan Kettering and has published extensively on radiation dose optimization for thoracic cancers.
Education & Training
- Medical Degree — Columbia University College of Physicians and Surgeons (Medicine)
- Residency — Memorial Sloan Kettering Cancer Center (Radiation Oncology)
Specialties & Procedures
Clinical Specialties
- Radiation Oncology
- Thoracic Radiation
As a medical oncologist, Dr. Kenneth Rosenzweig focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Radiology — Radiation Oncology
Research Focus
Intensity-modulated radiation therapy (IMRT) for mesothelioma, hemithoracic radiation, and radiation dose optimization for pleural malignancies.
Notable Publications
- Hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. International Journal of Radiation Oncology, Biology, Physics, 2012.
Treatment Center
Dr. Kenneth Rosenzweig practices at Mount Sinai Health System in New York, NY.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What radiation technique does Dr. Rosenzweig use for mesothelioma?
Dr. Rosenzweig specializes in intensity-modulated radiation therapy (IMRT) for mesothelioma, which precisely targets radiation to the pleural surface while minimizing exposure to healthy tissue including the lungs and heart.
When is radiation used for mesothelioma?
Radiation therapy for mesothelioma is typically used after surgery (adjuvant therapy) to target remaining cancer cells, or as part of palliative care to relieve symptoms. Dr. Rosenzweig designs treatment plans as part of a multimodal approach.